Skip to content
This website uses cookies to help us understand the way visitors use our website. We can't identify you with them and we don't share the data with anyone else. If you click Reject we will set a single cookie to remember your preference. Find out more in our privacy policy.

COVID-19: Funding for innovators

Latest funding opportunities for companies and innovators with a potential COVID-19 related solution.

If you are a company or an innovator with a potential COVID-19 related solution please apply directly to the relevant funding agencies below.

National Institute for Health Research (NIHR)

Global Effort on Covid-19 (GECO) Health Research. Deadline: 28 September 2020
Global Effort on Covid-19 (GECO) Health Research is a new cross UK government funding call aiming to support applied health research that will address Covid-19 knowledge gaps. The focus is on understanding the pandemic and mitigating its health impacts in low and middle-income countries (LMIC). The call prioritises epidemiology, clinical management, infection control and health system responses.
Find out more and apply.

Travel and subsistence funding to support LMIC engagement during the Covid-19 outbreak. Deadline 31 December 2020
The awards will provide travel and subsistence funding to appropriately qualified public health professionals, clinicians and academics who wish to offer science and technical advice to support the immediate response to Covid-19 in low and middle-income countries. The awards are open to applicants who have a substantive position at a UK higher education institution or research organisation.
Find out more and apply.

The NIHR have published a standard registration to get funding for Covid-19 related studies. Learn more about NIHR’s response to COVID-19 here.

UK Space Agency

UK space technologies to boost NHS Coronavirus response
The UK Space Agency has opened a call for proposals process to fund space-enabled technology and services that can strengthen the NHS response to coronavirus. Satellite data and drone technology can help meet challenges such as delivering test kits, masks, gowns and goggles, managing infectious disease outbreaks and supporting the health and wellbeing of the nation.
An initial £2.6 million is being made available to fund a number of projects to develop hi-tech solutions to these challenges, in a joint initiative with the European Space Agency (ESA) in support of NHS England.
Find out more and apply.

UK Research and Innovation

UKRI Open call for research and innovation ideas to address COVID-19. No closing date
UKRI will support excellent proposals of up to 18 months duration which meet at least one of the following: a) New research or innovation with a clear impact pathway that has the potential (within the period of the award) to deliver a significant contribution to the understanding of, and response to, the COVID-19 pandemic and its impacts. b) Supports the manufacture and/or wide scale adoption of an intervention with significant potential. c) Gathers critical data and resources quickly for future research use.
Find out more and apply.

Innovate UK

Defence and Security Accelerator (DASA)

DASA: Coronavirus – £1million Defence innovation funding. Deadline: rolling deadlines*.
£1million fund available to fast-track innovations to aid the Armed Forces in the fight against Coronavirus. The call is open to any idea or novel approach that could boost the Ministry of Defence’s capabilities and work as part of the national effort against Coronavirus or similar future threats. This competition is part of DASA’s Open Call Competition. Find out more and apply.

For all other COVID-19 innovation and company enquiries fill out the Innovate UK funding template form here.

Covid-19 – Support for Businesses – for the latest information on UK Govt support available.

International funding


Fast Funding for Covid-19 Science. Deadline: 31 December 2020.
A new venture fund is offering grants of $10,000 to $500,000 to coronavirus researchers, and every grant decision will be made in less than 48 hours. 
Find out more and apply.


Bill & Melinda Gates Foundation, Wellcome & Mastercard COVID-19 Therapeutics Accelerator.
Up to $125 million in seed funding to speed-up the response to the COVID-19 epidemic by identifying, assessing, developing, and scaling-up treatments. The COVID-19 Therapeutics Accelerator will play a catalytic role by accelerating and evaluating new and repurposed drugs and biologics to treat patients with COVID-19 in the immediate term, and other viral pathogens in the longer-term. Find out more and apply.

Covid-19 – Other International Funding (and more) read KTN round-up 

UCLPartners AHSN Commercial Team

Nationally, the AHSN Network are part of a coordinated NHS response to identify and enable the implementation of technologies that respond to the developing COVID-19 pandemic, in particular solutions for remote consultation and patient monitoring, diagnostics and point-of-care testing.

If you would like to connect with UCLPartners AHSN commercial team, please could you complete the following form with information on how your technology could aid response to the current COVID-19 situation.

For more information please contact